Postoperative resistance to atracurium;POSTOPERATIVE RESISTENZENTWICKLUNG GEGENUBER ATRACURIUM

Anaesthesist

Volumn 46, Issue 11, 1997, Pages 974-978

  Knuttgen D ^a   Doehn, M ^a   Zeidler, D ^a  

^a KRANKENHAUS MERHEIM   (Germany)

Author keywords

Adverse effects; Atracurium; Infection; Inflammation

Indexed keywords

ATRACURIUM; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ARTICLE; BRONCHUS FISTULA; CASE REPORT; DRUG RESISTANCE; GENERAL ANESTHESIA; HUMAN; INFLAMMATION; LUNG RESECTION; MALE; NEUROMUSCULAR BLOCKING; RESPIRATORY TRACT INTUBATION; SUPERINFECTION; THORACOTOMY; THORAX SURGERY; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD;

ADULT; ANESTHESIA, GENERAL; ATRACURIUM; DRUG RESISTANCE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; THORACIC SURGICAL PROCEDURES;

EID: 0030668162     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050495     Document Type: Article

References (19)

1. Bauer M (1996) Pathophysiologie der Sepsis. Anaesthesist 45:312-322
2. Bell CF, Hunter JM, Jones RS, Utting JE (1985) Use of atracurium and vecuronium in patients with oesophageal varices. Br J Anaesth 57:160-168
3. Brett RS, Schmidt JH, Gage JS, Schartel SA, Poppers PJ (1987) Measurement of acetylcholine receptor concentration in skeletal muscle from a patient with multiple sclerosis and resistance to atracurium. Anesthesiology 66:837-839
4. Dwersteg JF, Pavlin EG, Heimbach DM (1986) Patients with burns are resistant to atracurium. Anesthesiology 65:517-520
5. Foldes FF, Deery A (1983) Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases. Br J Anaesth 55:31S-34S
6. Forsyth SF, Ilkiw JE, Hildebrand SV (1990) Effect of gentamicin administration on the neuromuscular blockade induced by atracurium in cats. Am J Vet Res 51:1675-1678
7. Garcia E, Calvo R, Rodriguez-Sasiain M, Jimenez R, Trogoniz F, Suarez E (1995) Resistance to atracurium in rats with experimental inflammation: role of protein binding. Acta Anaesthesiol Scand 39:1019-1023
8. Hunter JM, Jones RS, Utting JE (1984) Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal functions. Br J Anaesth 56:941-951
9. Hunter JM (1991) Resistanceto non-depolarizing neuromuscular blocking agents (Editorial). Br J Anaesth 67:511-514
10. Luleci N, Akturk G, Kalac N (1994) Resistance to atracurium: Wegener's Granulomatosis -a case report. Mid East J Anaesth 12:511-515
11. Marathe PH, Dwersteg JF, Pavlin EG, Haschke RH, Heimbach DM, Slattery JT (1989) Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humans. Anesthesiology 70:752-755
12. Martineau RJ, St.-Jean B, Kitts JB, Curran MC, Lindsay P, Hull KA, Miller DR (1992) Cumulation and reversal with prolonged infusions of atracurium and vecuronium. Can J Anaesth 39:670-676
13. Mills AK, Martyn JA (1988) Evaluation of atracurium neuromuscular blockade in pediatric patients with burn injury. Br J Anaesth 60:450-455
14. Moorthy SS, Hilgenberg JC (1980) Resistance to nondepolarizing muscle relaxants in paretic upper extremities of patients with residual hemiplegia. Anesth Analg 59:624-627
15. Parker JR, Hunter JM (1989) Pharmaco-kinetics of atracurium and laudanosine in patients with hepatic cirrhosis. Br J Anaesth 62:177-183
16. Robinson BJ, Lee E, Rees D, Purdie GL, Galletly DC (1992) Betametasone-induced resistance to neuromuscular blockade: a comparison of atracurium and vecuronium in vitro. Anaesth Analg 74:762-765
17. Tatman AJ, Wrigley SR, Jones RM (1991) Resistance to atracurium in a patient with an increase in plasma alpha 1 globulins. Br J Anaesth 67:623-625
18. Tempelhoff R, Modica P, Jellish W, Spitznagel EL (1990) Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg 71:665-669
19. Vandenbrom RH, Wierda JM, Agoston S (1990) Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Clin Pharmacokin 19:230-240